Form 4: Aptiv CFO Plans Share Sale Under 10b5-1 Plan

Aptiv's EVP & CFO, Varun Laroyia, reported a planned sale of 5,000 ordinary shares for $80.05 each on December 12, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Varun Laroyia, Executive Vice President and Chief Financial Officer of Aptiv PLC, filed a Form 4 reporting a planned transaction.
• The transaction involves the disposition of 5,000 ordinary shares of Aptiv PLC.
• The shares are scheduled to be sold on December 12, 2025, at a price of $80.05 per share.
• This sale is being conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Laroyia on September 4, 2025.
• Following the execution of this planned transaction, Mr. Laroyia will beneficially own 150,769 ordinary shares directly.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned sale under a 10b5-1 plan, which is a routine event for executives managing their personal portfolios and does not typically signal a change in company outlook. Therefore, the sentiment is neutral.

Positives

• The sale is part of a pre-arranged Rule 10b5-1 trading plan, adopted on September 4, 2025, which indicates a scheduled, non-discretionary transaction rather than a reaction to immediate market conditions.

Negatives

• The planned sale by a key executive reduces their direct ownership stake in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine event for executives managing their personal portfolios and does not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Minor reduction in direct insider ownership, which is generally a neutral event when conducted under a pre-arranged 10b5-1 plan.

Key Dates

Recommendation

The reported transaction is a pre-scheduled sale by an executive under a Rule 10b5-1 trading plan. Such routine transactions are typically for personal financial planning and do not usually indicate a change in the company's fundamentals or warrant a shift in investment recommendation. Investors should continue to evaluate Aptiv based on its broader financial performance and strategic initiatives.

Keywords

Aptiv, APTV, insider trading, Form 4, share sale, executive compensation, 10b5-1 plan